Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
09/2003
09/03/2003EP1340768A2 LHRH analogues for the treatment of osteoporosis
09/03/2003EP1340754A1 Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
09/03/2003EP1339744A2 Production of recombinant bmp-2
09/03/2003EP1339737A2 Immunomodulatory protein derived from the yaba monkey tumor virus
09/03/2003EP1339721A2 Hydroxyesters of 7-desmethylrapamycin
09/03/2003EP1339716A1 Novel lactame-substituted pyrazolopyridine derivatives
09/03/2003EP1339711A1 Aminothiazoles and their use as adenosine receptor antagonists
09/03/2003EP1339710A1 3-oxadiazol-5-yl-1-aminoalkyl-1h-indole derivatives
09/03/2003EP1339709A1 Farnesyl transferase inhibiting benzoheterocyclic derivatives
09/03/2003EP1339708A2 Indole-type inhibitors of p38 kinase
09/03/2003EP1339698A2 Pyrimidine derivatives
09/03/2003EP1339691A1 Novel compounds
09/03/2003EP1339687A1 4-6-diphenyl pyridine derivatives as antiinflammatory agents
09/03/2003EP1339683A2 Estrogen receptor modulators
09/03/2003EP1339679A1 3-arylindole derivatives and their use as cb2 receptor agonists
09/03/2003EP1339678A2 Ep4 receptor selective agonists in the treatment of osteoporosis
09/03/2003EP1339663A2 Naphthalene derivatives
09/03/2003EP1339662A1 Novel estrogen receptor ligands and methods iii
09/03/2003EP1339424A2 Modulation of pericyte proliferation using bpi protein products or bpi inhibitors
09/03/2003EP1339411A2 Use of bisphosphonates for pain treatment
09/03/2003EP1339405A1 Use of anti-muscarinic agents and calcium channel blockers in combination
09/03/2003EP1339402A2 Benzoazepine and benzodiazepine derivatives and their use as parp inhibitors
09/03/2003EP1339294A1 Nutritional composition for an immune condition
09/03/2003EP1233794B1 A bioabsorbable drug delivery system
09/03/2003EP1196414B1 Prodrugs of carbamate inhibitors of impdh
09/03/2003EP0977741B1 Substituted phenyl derivatives, their preparation and use
09/03/2003EP0977733B1 Arylsulfonylamino hydroxamic acid derivatives
09/03/2003EP0973792B1 16-hydroxy-11-(substituted phenyl)-estra-4,9-diene derivatives
09/03/2003EP0876359B1 (-) cis-6(s)-phenyl-5(r) 4-(2-pyrrolidin-1-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol d-tartrate
09/03/2003CN1440408A Inhibitors of human phosphatidyl-inositol 3-kinase delta
09/03/2003CN1440405A Sulfonyl-pyrrolidine derivatives useful for treatment of neurological disorders
09/03/2003CN1440396A Colchinol derivatives as angiogenesis inhibitors
09/03/2003CN1440395A COLCHINOL derivatives as vascular damaging agents
09/03/2003CN1440392A Phenylpyridazine derivatives and drugs containing the same
09/03/2003CN1440383A PPARγ调制剂 PPARγ modulators
09/03/2003CN1440294A Medical components comprising human parathyroid hormone and medicinal compositions for nasal administration containing the components
09/03/2003CN1439641A Anti-cancer chemicals of methotrexate derivatives and their uses in pharmaceutical science
09/03/2003CN1439417A External used medicine for traumatic injury and preparation thereof
09/03/2003CN1439414A Chinese medicine for ftracture and preparation thereof
09/03/2003CN1439399A Blood promoting and bone strenglhening pellets
09/03/2003CN1439395A Chinese medicine formula for osteoproliferation
09/03/2003CN1439390A Capsule for protrusion of vertebral disc and its preparation
09/03/2003CN1439385A Chinese medicine for rheumatism
09/03/2003CN1439382A Chinese medicinal herb paste for fractures and preparation thereof
09/03/2003CN1439380A Degradable apisin microballoons injection and preparation thereof
09/03/2003CN1439377A Composition for improvement of osteoporosis
09/03/2003CN1439367A Pratensein extraction and preparation thereof
09/03/2003CN1120017C Tendon injure treating spray and its preparation
09/03/2003CN1120014C Chinese patent medicine for treating hyperosteogeny
09/03/2003CN1120012C Preparation of orthopaedic and traumatological medicine
09/02/2003US6613920 25-(5-propylimidazol-2-yl)-26,27-cyclo-9, 10-secocholesta-5,7,10(19),22-tetraene-1,3,24-triol; antagonizes the action of calcitriol in HL 60 cells; hyperprolifierative diseases of the skin, tumor diseases and precancerous stages
09/02/2003US6613911 Reaction of haloarylacetic acids or esters with olefins to give vinylarylacetic acids or esters, oxidation with an oxidizing reagent gives formylarylacetic acids or esters
09/02/2003US6613905 Chemokine receptor antagonists and methods of use therefor
09/02/2003US6613802 Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
09/02/2003US6613794 Inhibiting tumor necrosis factor alpha, treating eosinophil-related condition, treating inflammatory airway disorder
09/02/2003US6613791 N-substituted azaheterocyclic carboxylic acids and their use
09/02/2003US6613778 Imidazopyridine derivatives as phosphodiesterase VII inhibitors
09/02/2003US6613770 Quinoline derivatives as NK-2 and NK-3 receptor ligands
09/02/2003US6613769 Tryptase inhibitors
09/02/2003US6613760 Indole derivatives and their use as MCP-1 receptor antagonists
09/02/2003US6613739 Immunosuppressants
08/2003
08/28/2003WO2003071281A2 Estrogen receptor interaction with a transcription factor
08/28/2003WO2003071273A1 Method of detecting bond between vitamin d3 derivative and vitamin d3 receptor
08/28/2003WO2003070970A2 RNA INTERFERENCE MEDIATED INHIBITION OF NF-KAPPA B/REL-A GENE EXPRESSION USING SHORT INTERFEREING NUCLEIC ACID (siNA)
08/28/2003WO2003070968A2 RNA INTERFERENCE MEDIATED INHIBITION OF GASTRIC INHIBITORY POLYPEPTIDE (GIP) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070918A2 Rna interference by modified short interfering nucleic acid
08/28/2003WO2003070914A2 RNA INTERFERENCE MEDIATED INHIBITION OF FOS GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070911A2 Rna interference mediated inhibition of type 1 insulin-like growth factor receptor (igf-1r)
08/28/2003WO2003070910A2 INHIBITION OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) AND VEGF RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070903A2 RNA INTERFERENCE MEDIATED INHIBITION OF GRB2-ASSOCIATED BINDING PROTEIN 2 (GAB2) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070886A2 Inhibition of protein tyrosine phosphatase type iva expression byshort interfering nucleic acid
08/28/2003WO2003070744A1 RNA INTERFERENCE MEDIATED INHIBITION OF INTERLEUKIN GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070727A1 Thiazolyl urea compounds for the treatment of cancer
08/28/2003WO2003070716A1 Vitamin d3 derivatives and remedies using the same
08/28/2003WO2003070711A1 Oxa- and thiadiazoles and their use as metalloproteinase inhibitors
08/28/2003WO2003070706A1 Tricyclic pyrazole derivatives for the treatment of inflammation
08/28/2003WO2003070697A1 Method of assaying activity of binding to vitamin d3 receptor using fluorescence polarization
08/28/2003WO2003070675A2 Substituted 10-aryl-11h-benzo[b]fluorenes and 7-aryl-5,6-dihydro-benzo[a]anthracenes for selective effects on estrogen receptors
08/28/2003WO2003070267A1 Enhancing the availability of minerals by using biologically active peptides
08/28/2003WO2003070251A1 Pharmaceutical combinations of cox-2 inhibitors and opiates
08/28/2003WO2003070242A1 Piperidin-4-yl urea derivatives and related compounds as chemokine receptor inhibitors for the treatment of inflammatory diseases
08/28/2003WO2003070237A1 Combinations of an alpha-2-delta ligand with a selective inhibitor of cyclooxygenase-2
08/28/2003WO2003070236A2 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents
08/28/2003WO2003070235A1 Medicinal compositions for inhibiting tryptase
08/28/2003WO2003070197A2 RNA INTERFERENCE MEDIATED INHIBITION OF TGF-BETA AND TGF-BETA RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070192A2 Compositions and methods for surrogate antibody modulation of an immune response and transport
08/28/2003WO2003070190A2 Surrogate antibodies and methods of preparation and use thereof
08/28/2003WO2003070188A2 Method of treating trx mediated diseases
08/28/2003WO2003070166A2 Novel tyloindicines and related processes, pharmaceutical compositions and methods
08/28/2003WO2003031447A3 Pyrimidine derivatives
08/28/2003WO2003016335A3 Irreversible cysteine protease inhibitors of legumain
08/28/2003WO2003013434A3 Methods and compositions for treating diseases associated with excesses in ace
08/28/2003WO2003007879A3 Cartilage repair and regeneration scaffold and method
08/28/2003WO2003002105A3 Use of tyrosine kinase inhibitors for treating bone loss
08/28/2003WO2003002058A3 Bone anabolic compounds and methods of use
08/28/2003WO2002097044A3 Alternative splice forms of proteins as basis for multiple therapeutic modalities
08/28/2003WO2002094192A3 Antibodies against tumor necrosis factor delta (april)
08/28/2003WO2002081521A3 Osteoprotegerin in milk
08/28/2003WO2002072534A3 1-butane acid derivatives, pharmaceutical compositions containing said derivatives and the use thereof
08/28/2003WO2002046749A3 Screening method for identifying compounds that selectively induce interferon alpha
1 ... 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 ... 820